Rachel Chhiba
Foot & Ankle Surgery · Indianapolis, INNPI 1720406564
Payments from drug & device makers
Across 32 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$555
- Aroa Biosurgery Incorporated$80
- Averitas Pharma Inc.$79
- Acera Surgical, Inc.$29
- Kerecis Limited$28
- DJO, LLC$26
- plus $106 from 5 others
What the payments were for
- Food & beverage$86496%
- Education$394%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 20 | $555 |
| Aroa Biosurgery Incorporated | 1 | $80 |
| Averitas Pharma Inc. | 3 | $79 |
| Acera Surgical, Inc. | 1 | $29 |
| Kerecis Limited | 1 | $28 |
| DJO, LLC | 1 | $26 |
| Derma Sciences, Inc. | 1 | $26 |
| Sanara Medtech Inc. | 1 | $24 |
| Smith+Nephew | 1 | $20 |
| Alafair Biosciences, Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $16 |
How this compares
$903 in reported general payments places this provider in the 15th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $12,724 |
| Gabapentin | 32 | $959 |
| Ketoconazole | 38 | $952 |
| Ciclopirox | 26 | $577 |
| Cephalexin | 45 | $283 |
| Methylprednisolone | 34 | $195 |
| Terbinafine Hcl | 11 | $175 |
| Clindamycin Hcl | 17 | $121 |
| Silver Sulfadiazine | 24 | $85 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $72 |
| Meloxicam | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Indianapolis
- Patrick DeheerIndianapolis$493K
- Stephen GreenfieldIndianapolis$52K
- Mihir PatelIndianapolis$28K
- Cathy CokerIndianapolis$23K
- Jered StowersIndianapolis$14K
- Zachary JanesIndianapolis$13K
- Neal PatelIndianapolis$12K
- Tracy WarnerIndianapolis$10K
- Elizabeth ParryIndianapolis$10K
- Steven HerbstMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.